ESC Congress 2024

  30 Aug 2024 - 02 Sep 2024

   London - United Kingdom of Great Britain and Northern Ireland

conference-img

ESC Congress 2024

30 Aug 2024

 - 

02 Sep 2024

London - United Kingdom of Great Britain and Northern Ireland



Delve into ground-breaking research, learn about practice-chancing science and experience unmissable networking opportunities to drive your career forward and shape the future of cardiovascular medicine. The Spotlight of ESC Congress 2024 will be 'Personalising Cardiovascular Care’; a topic devoted to empowering patients through tailored treatments to improve outcomes, reduce risk, and redefine the standard of care.

Together, the global cardiology community will converge in London with the shared goal of advancing cardiovascular medicine worldwide. Wherever you are in the world, we hope you join us on the journey to the heart of cardiology, in person or online at ESC Congress 2024.

International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


International Conference on Sexual and Reproductive Health

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


International Conference on Sexual and Reproductive Health

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

2.

FDA approves Blenrep for relapsed or refractory multiple myeloma

3.

X-ray and radar technology combined to reduce cancer screening risks

4.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

5.

Researchers discuss HER2-low and HER2-zero in breast cancer

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot